Atlas Trials

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Clinical trial NCT02265536 · COMPLETED

Trial details

NCT number
NCT02265536
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NeoplasmsNeoplasm Metastasis
Start date
2015-05-01
Primary completion
2017-11-03
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.